Genmab — Juli 2022

[Helge_LarsenPI-redaktør]

Copenhagen Compounder
@cphcompounder/Twitter
·$XBI er oppe 17% siden den bund i Maj som også var bunden i ‘18 og ‘20. Den lavere rente pga frygt for recession sender lige nu investorerne ud af ‘value’ og tilbage ind i bl.a. biotech - og tror først lige den bevægelse er startet. https://twitter.com/cphcompounder/status/1544550148788944896

[Bulder]

Betydeligt større omsætning end de foregående dage. 22k på 20 min.

[Monforte]

@Bikube 5/7 kl 15:52. Tak for din opmærksomhed. Der er ikke de store ændringer. DARA virker stadig upåklageligt efter 104 sekvenser.

[JKY_VH]

Det er vi mange der er glade for at høre;-)

[E_L]

Abstract LB087: Characterization of JNJ-70218902, a TMEFF2 x CD3 bispecific antibody, in prostate cancer models https://aacrjournals.org/cancerres/article/82/12_Supplement/LB087/703769

[bikube]

Monforte - Dejligt at høre. Som jeg har sagt før, så må folk finde på noget andet at dø af.

[E_L]

this Mim8 safety trial completed
https://clinicaltrials.gov/ct2/history/NCT05127473?A=5&B=6&C=merged#StudyPageTop

[Hamming]

Oversigt over bispecifikke i prostata kræft: https://www.targetedonc.com/view/advancing-t-cell-redirecting-agents-in-prostate-cancer

[E_L]

and this one is interesting; was set to Active, not recruiting , last november, at 101 [Actual] enrolled; now it appears the date is extended and suddenly 275 have enrolled https://clinicaltrials.gov/ct2/history/NCT04204408?A=46&B=47&C=merged#StudyPageTop

[Hamming]

Inclacumab har fået orphan drug + rare pediatric disease designation https://www.hcplive.com/view/fda-sickle-cell-treatments-orphan-drug-status

[bikube]

Jeg bemærker lige, at de stadig sælger nye aktier for warrants, de har da ellers nok aktier på lager at tage af.

[E_L]

that's nice! good find Hamming!

[E_L]

we may hear a bit more on Mim8 from Novo next month -Novo Nordisk announces innovation plans in rare blood disorders’ treatment- https://www.financialexpress.com/healthcare/pharma-healthcare/novo-nordisk-announces-innovation-plans-in-rare-blood-disorders-treatment/2577047/

[bikube]

Angående dagens kursudvikling - skal vi mon ned og lukke gapet fra i morges ?

[E_L]

was just looking at the same; we did close the gap on day basis, so that could be enough; it is also a backtest of the downtrendline that is in the proces of being broken (formulating it carefully here lol)

[E_L]

we practically hit the 50% recovery from the 3124 > 1863 dive this morning
(= 2494)

[bikube]

Gap er lukket - luk i går 2407 - day low 2406 i dag.

[Sukkeralf]

FDA grants Priority Review to Roche’s Lunsumio for people with relapsed or refractory follicular lymphoma

[Sukkeralf]

https://firstwordpharma.com/story/5608755

[E_L]

not sure if anybody is still inerested in -Enapotamab Vedotin, an AXL-Specific Antibody-Drug Conjugate, Demonstrates Antitumor Efficacy in Patient-Derived Xenograft Models of Soft Tissue Sarcoma https://www.mdpi.com/1422-0067/23/14/7493/htm